nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—enteric nervous system—narcolepsy	0.213	0.35	CbGeAlD
Tapentadol—SLC6A2—locus ceruleus—narcolepsy	0.0944	0.155	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—narcolepsy	0.0502	0.0824	CbGeAlD
Tapentadol—OPRD1—forebrain—narcolepsy	0.0234	0.0384	CbGeAlD
Tapentadol—OPRK1—forebrain—narcolepsy	0.0225	0.0369	CbGeAlD
Tapentadol—HTR3A—brainstem—narcolepsy	0.018	0.0296	CbGeAlD
Tapentadol—HTR3A—forebrain—narcolepsy	0.0174	0.0286	CbGeAlD
Tapentadol—OPRM1—brainstem—narcolepsy	0.0165	0.0272	CbGeAlD
Tapentadol—OPRM1—forebrain—narcolepsy	0.016	0.0262	CbGeAlD
Tapentadol—SLC6A4—brainstem—narcolepsy	0.0138	0.0226	CbGeAlD
Tapentadol—SLC6A4—forebrain—narcolepsy	0.0133	0.0218	CbGeAlD
Tapentadol—SLC6A2—brainstem—narcolepsy	0.0121	0.0199	CbGeAlD
Tapentadol—SLC6A2—forebrain—narcolepsy	0.0117	0.0192	CbGeAlD
Tapentadol—SLC6A4—Monoamine Transport—HRH3—narcolepsy	0.0116	0.0298	CbGpPWpGaD
Tapentadol—OPRM1—midbrain—narcolepsy	0.0105	0.0173	CbGeAlD
Tapentadol—SLC6A2—Monoamine Transport—HRH3—narcolepsy	0.01	0.0256	CbGpPWpGaD
Tapentadol—OPRD1—brain—narcolepsy	0.00972	0.016	CbGeAlD
Tapentadol—OPRK1—brain—narcolepsy	0.00932	0.0153	CbGeAlD
Tapentadol—SLC6A4—midbrain—narcolepsy	0.00877	0.0144	CbGeAlD
Tapentadol—SLC6A2—medulla oblongata—narcolepsy	0.00845	0.0139	CbGeAlD
Tapentadol—HTR3A—brain—narcolepsy	0.00723	0.0119	CbGeAlD
Tapentadol—CYP2D6—brainstem—narcolepsy	0.00663	0.0109	CbGeAlD
Tapentadol—OPRM1—brain—narcolepsy	0.00663	0.0109	CbGeAlD
Tapentadol—CYP2D6—forebrain—narcolepsy	0.0064	0.0105	CbGeAlD
Tapentadol—OPRD1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00559	0.0143	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00559	0.0143	CbGpPWpGaD
Tapentadol—SLC6A4—brain—narcolepsy	0.00551	0.00905	CbGeAlD
Tapentadol—SLC6A4—Circadian rythm related genes—HCRTR2—narcolepsy	0.0049	0.0125	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—HCRTR1—narcolepsy	0.0049	0.0125	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0049	0.0125	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0049	0.0125	CbGpPWpGaD
Tapentadol—SLC6A2—brain—narcolepsy	0.00485	0.00797	CbGeAlD
Tapentadol—OPRD1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00459	0.0117	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00437	0.0112	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00437	0.0112	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00435	0.0111	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00422	0.0108	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00414	0.0106	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00414	0.0106	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00409	0.0105	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00402	0.0103	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00383	0.00981	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00383	0.00981	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00375	0.00959	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00375	0.00959	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0037	0.00948	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00362	0.00926	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00359	0.00917	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00348	0.00889	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—PENK—narcolepsy	0.00345	0.00882	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00341	0.00873	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0034	0.0087	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00329	0.00841	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00329	0.00841	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00324	0.00829	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00324	0.00829	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00317	0.00812	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00313	0.00801	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00308	0.00787	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00305	0.0078	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00303	0.00775	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.00302	0.00774	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00285	0.0073	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00285	0.0073	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00278	0.0071	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00278	0.0071	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—P2RY11—narcolepsy	0.00276	0.00705	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00274	0.00702	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00272	0.00695	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0027	0.0069	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00268	0.00686	CbGpPWpGaD
Tapentadol—CYP2D6—brain—narcolepsy	0.00266	0.00436	CbGeAlD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00262	0.0067	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00258	0.00659	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—HRH3—narcolepsy	0.00257	0.00658	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.00256	0.00654	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00253	0.00646	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00253	0.00646	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.0025	0.0064	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.0025	0.0064	CbGpPWpGaD
Tapentadol—SLC6A4—Monoamine Transport—TNF—narcolepsy	0.00249	0.00638	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.00242	0.00618	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0024	0.00615	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00239	0.00611	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HCRT—narcolepsy	0.00234	0.00599	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00233	0.00597	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00228	0.00583	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.00226	0.00577	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—NPS—narcolepsy	0.00222	0.00567	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00221	0.00567	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00221	0.00567	CbGpPWpGaD
Tapentadol—SLC6A2—Monoamine Transport—TNF—narcolepsy	0.00215	0.00549	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00211	0.00541	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00211	0.00541	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00209	0.00535	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—PENK—narcolepsy	0.00209	0.00534	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.00205	0.00526	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00204	0.00523	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00204	0.00523	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00204	0.00522	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00203	0.0052	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.002	0.00512	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00191	0.00488	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00187	0.00479	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00187	0.00479	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00183	0.00468	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00179	0.00459	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TRH—narcolepsy	0.00178	0.00454	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00177	0.00452	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00174	0.00444	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00173	0.00442	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00169	0.00433	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00169	0.00433	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00163	0.00418	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00161	0.00413	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00161	0.00413	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00156	0.00398	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.00156	0.00398	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00156	0.00398	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00155	0.00396	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00154	0.00394	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00152	0.00388	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00149	0.0038	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00149	0.0038	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00146	0.00375	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00146	0.00375	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00141	0.00362	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00141	0.00362	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00141	0.00362	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00137	0.00349	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00137	0.00349	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00136	0.00348	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00132	0.00339	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00132	0.00337	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.00129	0.0033	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.00129	0.0033	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.00128	0.00328	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.00128	0.00328	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00126	0.00321	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00126	0.00321	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.00124	0.00317	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.0012	0.00308	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00119	0.00306	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00119	0.00306	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00119	0.00304	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.00118	0.00302	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.00116	0.00297	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00115	0.00295	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00115	0.00295	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00113	0.00289	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00113	0.00289	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00113	0.00288	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CHKB—narcolepsy	0.0011	0.0028	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00109	0.00278	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00109	0.00278	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.00107	0.00274	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00105	0.0027	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00105	0.00268	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00104	0.00267	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.00103	0.00265	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00102	0.00261	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.001	0.00257	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.000981	0.00251	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.000956	0.00245	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.000956	0.00245	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00094	0.0024	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.00094	0.0024	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.000911	0.00233	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000894	0.00229	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.000891	0.00228	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CHKB—narcolepsy	0.000891	0.00228	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000882	0.00226	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.00088	0.00225	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.00088	0.00225	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.000875	0.00224	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000865	0.00221	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000865	0.00221	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000857	0.00219	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.000835	0.00214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.000799	0.00204	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.000799	0.00204	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.000794	0.00203	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000776	0.00199	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.000772	0.00197	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000758	0.00194	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000758	0.00194	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000755	0.00193	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CPT1B—narcolepsy	0.000745	0.00191	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.000744	0.0019	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.000733	0.00187	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.000729	0.00187	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000729	0.00187	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.00071	0.00182	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000702	0.0018	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.000701	0.00179	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.000681	0.00174	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.000675	0.00173	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.000662	0.00169	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.000662	0.00169	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000652	0.00167	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000641	0.00164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000641	0.00164	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.000639	0.00164	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.000639	0.00164	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000639	0.00163	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PENK—narcolepsy	0.000633	0.00162	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.000623	0.00159	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.000619	0.00158	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CPT1B—narcolepsy	0.000605	0.00155	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.000592	0.00152	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000582	0.00149	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.000581	0.00149	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.000581	0.00149	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000575	0.00147	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PENK—narcolepsy	0.000555	0.00142	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00054	0.00138	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.00054	0.00138	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TRH—narcolepsy	0.000538	0.00138	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.000526	0.00135	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.000491	0.00126	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.000491	0.00126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TRH—narcolepsy	0.000472	0.00121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.000472	0.00121	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PENK—narcolepsy	0.000469	0.0012	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000439	0.00112	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CHKB—narcolepsy	0.000419	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.000414	0.00106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TRH—narcolepsy	0.000399	0.00102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000398	0.00102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.000391	0.001	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NPS—narcolepsy	0.000391	0.001	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CHKB—narcolepsy	0.000385	0.000985	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.000385	0.000984	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CHKB—narcolepsy	0.000382	0.000976	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.00035	0.000895	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000349	0.000894	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000343	0.000877	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000343	0.000877	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000325	0.000832	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000295	0.000755	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.00029	0.000742	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—narcolepsy	0.00029	0.000742	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000284	0.000728	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000262	0.000669	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000259	0.000664	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000235	0.000602	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000206	0.000528	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000174	0.000446	CbGpPWpGaD
